These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29062994)

  • 1. Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease.
    Cen JM; Cheng J; Xiong QY; Mei BQ; Cai WB; Yang XL
    Chronic Dis Transl Med; 2015 Jun; 1(2):105-109. PubMed ID: 29062994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the serum lipoprotein-associated phospholipase A
    Dong L; Tong J; Fan S
    Cardiovasc J Afr; 2023 Nov-Dec 23; 34(5):273-277. PubMed ID: 36637451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IMA and LP-PLA2 Levels in Patients with Coronary Heart Disease and Their Correlation with the Degree of Myocardial Ischaemia and Their Diagnostic Value.
    Zhang L; Li Z; Li N
    Emerg Med Int; 2022; 2022():1698315. PubMed ID: 35726302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between serum inflammatory cytokine levels and fibrous cap thickness of fibrofatty plaque in coronary culprit lesions].
    Zhong Y; Ye F; You W; Wu ZM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jul; 45(7):566-571. PubMed ID: 28738484
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating Oxidized Low-Density Lipoprotein is a Strong Risk Factor for the Early Stage of Coronary Heart Disease.
    Zhang Q; Ai Y; Dong H; Wang J; Xu L
    IUBMB Life; 2019 Feb; 71(2):277-282. PubMed ID: 30414358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
    Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
    Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
    Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change of Inflammatory Factors in Patients with Acute Coronary Syndrome.
    Ma CY; Xu ZY; Wang SP; Peng HY; Liu F; Liu JH; Ren FX
    Chin Med J (Engl); 2018 Jun; 131(12):1444-1449. PubMed ID: 29893361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of lipoprotein-associated phospholipase A2 in healthy Chinese Han adult serum.
    Feng LM; Feng GF; Chen Y
    Lipids Health Dis; 2014 Jan; 13():6. PubMed ID: 24393260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
    Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
    Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects.
    Schaefer EJ; McNamara JR; Asztalos BF; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2005 May; 95(9):1025-32. PubMed ID: 15842965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of plasma galectin-3 and plasma lipoprotein-associated phospholipase A2 with the severity and prognosis of coronary artery disease.
    Wang R; Wang X; Zhang E; Li F; Zhang P; Shi J
    Am J Transl Res; 2021; 13(8):8997-9004. PubMed ID: 34540011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of serum lipoprotein-related phospholipase A2 in patients with white matter lesion based on KIM classification and its correlation with carotid atherosclerotic plaque].
    Zhang W; Zhang YM; Li LL; Xia Y; Zhou X; Zhu XQ; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1130-1135. PubMed ID: 32311875
    [No Abstract]   [Full Text] [Related]  

  • 15. Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis.
    Zhang J; Xu DL; Liu XB; Bi SJ; Zhao T; Sui SJ; Ji XP; Lu QH
    Yonsei Med J; 2016 Mar; 57(2):321-7. PubMed ID: 26847282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Lp-PLA2 and coronary heart disease in Chinese patients.
    Yang L; Liu Y; Wang S; Liu T; Cong H
    J Int Med Res; 2017 Feb; 45(1):159-169. PubMed ID: 28222638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic efficacy and predictive value of combined lipoprotein laboratory indexes for atherosclerosis.
    Xiao W; Yang Y; Shi J; Xu J; Zhu J; Wu Z
    J Pak Med Assoc; 2020 Sep; 70 [Special Issue](9):115-119. PubMed ID: 33177739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study.
    White HD; Simes J; Stewart RA; Blankenberg S; Barnes EH; Marschner IC; Thompson P; West M; Zeller T; Colquhoun DM; Nestel P; Keech AC; Sullivan DR; Hunt D; Tonkin A;
    J Am Heart Assoc; 2013 Oct; 2(5):e000360. PubMed ID: 24152981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between lipoprotein-associated phospholipase A2 with cardiovascular risk factors in testosterone deficiency.
    Keleşoğlu M; Kızılay F; Barutçuoğlu B; Başol G; Saraç F; Mutaf I; Semerci B
    Turk J Urol; 2018 Mar; 44(2):103-108. PubMed ID: 29511577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of serum lipoprotein-associated phospholipase A2, ischemia-modified albumin, and cystatin C in predicting coronary heart disease risk: a single center retrospective cohort study.
    Le QF; Liu J; Chen L
    Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10730-10735. PubMed ID: 37975398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.